Despite a strenuous past year in the medtech industry, the global medtech contract development and manufacturing (CDMO) market has continued to grow steadily, reaching $81.5B in 2023. Over half of worldwide industry revenues can be attributed to the resilient performance of more than 600 CDMOs across European and US markets.
This webinar will investigate the current state of the global medtech CDMO industry and highlight Europe as a promising frontier for consolidation. Attendees will get key insights surrounding this dynamic market, including:
The market trends that impact the performance of global medtech CDMOs today
An assessment of Western Europe’s CDMO landscape that identifies the region’s core capabilities and end markets
A 2024 outlook for medtech CDMOs that contextualizes mergers and acquisitions (M&A) activity from 2023 with expected market opportunities and risks